Cardiotoxicity of antitumor agents.
D000818:Animals; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004562:Electrocardiography; D005472:Fluorouracil / Q000009:adverse effects; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009206:Myocardium / Q000473:pathology; D009279:Naphthacenes / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009279:Naphthacenes; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil